Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | MAT2A | P31153 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10328390 | 0.94 | MEN1 (0.45) | MEN1KMT2ACYP1A2TSHRALDH1A1 | |
| SCHEMBL19166259 | 0.89 | MEN1 (0.38) | MEN1KMT2ACYP1A2TSHRALDH1A1 | |
| SCHEMBL582039 | 0.88 | MEN1 (0.52) | MEN1KMT2ACYP1A2TSHRALDH1A1 | |
| SCHEMBL1131137 | 0.84 | HSP90AA1 (0.44) | MEN1KMT2ACYP1A2TSHRALDH1A1 | |
| SCHEMBL9433260 | 0.84 | POLB (0.40) | MEN1KMT2ACYP1A2TSHRALDH1A1 | |
| SCHEMBL9294465 | 0.83 | PDE4B (0.39) | MEN1KMT2ACYP1A2TSHRALDH1A1 | |
| SCHEMBL10672222 | 0.80 | MEN1 (0.48) | MEN1KMT2ACYP1A2ALDH1A1L3MBTL1 | |
| SCHEMBL10618087 | 0.79 | MEN1 (0.47) | MEN1KMT2ACYP1A2POLBPDE4B | |
| SCHEMBL6051593 | 0.76 | POLB (0.48) | MEN1KMT2ACYP1A2TSHRALDH1A1 | |
| SCHEMBL12613732 | 0.76 | MEN1 (0.43) | MEN1KMT2ACYP1A2TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180148421-A1 | Hybrid Scorch Retardant/Cure Co-Agent | DOW CHEMICAL (CHINA) INVESTMENT COMPANY LIMITED (CN) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180148421-A1 | Hybrid Scorch Retardant/Cure Co-Agent | BCOR, RCOR1, RCOR3 | MEN1 3818/4885KMT2A 586/4885CYP1A2 1282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.